Human papillomavirus (HPV) is a recently discovered causal agent for a subset of head and neck malignancies, especially in the oropharynx, and contributes largely to the increased global prevalence of oropharyngeal cancer (OPC). Individuals with HPV-positive OPC have different risk factor profiles and a better prognosis than individuals with conventional, HPV-negative head and neck cancer. To learn more about advances in surgical modalities for OPC, join the expert Oncologist Dr. Karthik Rajasekaran in our exclusive session on 10 th March 2025 , 6:00 PM IST onwards.
Stay tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements and graphics. We do not endorse any…
